Neuraxis (NRXS)

• Market cap: $24.9M
• 1 day: -0.43%
• 5 days: -12.03%
• 1 month: -22.77%
• 3 months: -1.27%
• 6 months: 3.08%
• Year to date: -0.43%
• 1 year: -28.44%
• 5 years: -61%
• 10 years: -61%
• Sector: Healthcare
• Industry: Medical Devices

About: Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Employees: 21